ASPARTATE AND GLUTAMATE MODULATION OF GROWTH
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The influence of excitatory amino acids (EAA) on growth honnone (OH) secretion and the
possible site of action was in ...estigated in the pig. In Experiment (Ex p) I three replicates were
cond ucted with 30 prepuberal gilts, 130 d of age and a"'e raging 70.6 ± 1.3 kg body weight (8W).
Six gi lts each reeei ...ed intra...enously (i ... ) 0, 50, 100, or ISO mglkg BW of aspartate (ASP) or
g lutamate (OLU) in saline. Blood samples were collectcd e ...cry IS min for 2 hr before and 3 hr after
treatmc nt. In Exp II. mature o ...arieetomized g ilts (1 63 ± 10 kg BW) lIIat had been immunizcd
agai nst growth honnone releasing factor (ORF) conjugated to human serum albumin (GRFi: n = 4)
or against hu man seru m albumin alone (HSAi; n '" 5) received ISO mglkg RW ASP or O LU i... in
a 2 x 2 factorial arrangement of treatments. whic h was then repeated in a crosso...er design. One
week later. all animals recei...ed 10 mglkg N-methyl-D,L.aspanatc (NMA: EAA ago nist) in saline i....
Blood samples wcre collected as described abo ... e. In Exp III. cultures of anteri or pituitary cells from
market-weight (a...eraging 105 kg BW) gilts were studied. On Day 4 of culture. cells ( IO' seeded!
well) were challenged with 10- 8, 10-6. or 10-4 M AS P or OLU, IO-{. M [Ala"l· human ORF
{1 - 29)-N H2' or the EAA antagonist, 2-am ino-5.phosphonopentanoic acid (1 0-4 M; AP5), alone or
in combination with AS P or OLU. In Exp I, al l doses of ASP and lIIe 100- and I 50-mg doses ofGLU
increased (P < 0.05) O H secretion whcn compared with Time O. However. seru m GH concentrations
we re high!::r (P < 0.0 1) after ISO mg/kg of AS P when compared with those after 150 mglkg of GLU.
In Ex p 11 , serum G H concentrations increased (P < 0.05) in HSAi but not in ORFi pigs (a ...eragi ng
1.2 ± 0.2 nglml before and 8.2:t 0.7, 6.3 ± 0.5, and 9.2 ± 0.5 nglml by 15 min after ASP, OlU, and
NMA, respect i...ely). In Exp Ill . re lati ...c to controls (40 ± 6 nglml). G H inc reased (P < 0.05) 1.6·,
1.9-. and 1.9-fol d and 1.7-, 1.8·, and 2.0-fold after 10- 8, 10-1>, and 10--' M AS P and GLU. respec
ti...ely. The BAA rece ptor a",agonist AP5 failed to preven t the OH response to AS P or OLU. except
for 10- 8 M AS P. In summary. AS P is a more potent secre tagog ue of O H secretion than is OLU in
... i...o, whereas each is equipotent in ...itro. Because no stimulation of G H by EAA was obser ...ed in
GR Fi pigs and no speci fic dose.response effect or EAA was found in ... itro. it may be concluded that
modulation by EAA is mediated pri marily at the le ...e1 of the hypo thalamus or higher brain centers.

INTRODUCTION
Excitatory amino acids (EAA), including g luta mate (GLU) and as partate ( ASP), have
bee n implicated as maj o r ne urotra ns mitte rs in the mam malian cenlra l ne rvo us syste m
(eNS) (I). Price e t al. (2) demo nstrated the prefere ntia l uptake of exogeno us ly adminis+
te red AS P a nd GLU by the c irc um venlric ular o rgans of the rat bra in, including the arc uate
nucle us. The syste mic inj ectio n of GLU inc reased GL U levcls foutfo ld in the me dia n

e minence, but nOI in other arcas of the hypothalamus in mice (3). N-Mcthyl-D,L-asparatc
(NMA), a potent agonist of ASP and GLU, stimulates the re lease of pituitary honnones.
including lute inizi ng hormone (LH) (4-6) and growth honnone (G H) (4,7.8). NMA stim
ulated GH secretion and accelerated growth in prepuberal monkeys (5) and dramatically
increased serum concentrations of GH in wethers (7) and ovariectomized ewes (8). In the
pig, NMA increased GH secretion without regard to steroid milie u (9). In contrast, the
NMA stimulation of GH secretion from pig pituitary cells in vitro was influenced by the
reproductive state of the pituitary donor ( 10). There is limited informalion on the influence
o f GLV and ASP on GH secretio n in Ihe pig. The objective of this study was to I)
detennine the effect of GLU and ASP on GH secretion and 2) determine if the action of
GLU and ASP appears to be directly on the pituitary and/or brain to mod ulate GH
secretion.
MATERIALS AND METHODS
Experiment I. The experimental protocols were approved by the Institutional Animal
Care and Use Committee. Founeen prepuberal gilts (Yorkshire x Landrace x Hampshire).
130 d of age and averaging 70.6 ± 1.3 kg body weight (BW). received 0 (control), 50. 100,
or 150 mglkg BW of ASP2 or GLU 2 in saline intravenously (iv). One week later, the
experiment was replicated with pigs reassigned to treatment such that no pig received the
same dose as before, res ulting in four pigs/dose of ASP. GLU, or ~a lin e. A third replicate
was conducted with an additional 16 prepuberal gi lts o f the same genetic base, 130 d of
age and averaging 70. 1 ± 1. 1 kg BW. Two gilts each received either ASP or GLU al the
doses described above. while four pigs acted as contro ls and received 0.9% saline iv. Thi s
resulted in six pigs/dose of ASP or GLU and eight control pigs across re pl icates. A
cannula was placed in the jugular vein of all pigs the day before treatment. On the day of
treatment. blood was col1ected cvcry 15 min for 2 hr before and 3 hr after treatment.
Serum was harvested and stored at - 20" C until assayed for GH by radioimmunoassay
(RIA ).

Experiment II. Mature ovariectomized pigs (Yorkshire x Hampshire; 163 ± 10 kg BW)
1010 12 mo nths of age that had been immunized against growth honno ne releasing factor
(GRF) (l·29)-(GlY).rCys-N H2 conjugated to human serum albumin (G RFi ; n == 4) or
against human serum albumin alone (HSAi: n == 5). as previously described (I I), received
ISO mglkg BW ASP or GLU iv in a 2 x 2 factorial arrangement of treat ments, which was
repeated 24 hr later in a crossover design. One week later. all pigs were treated with NMA
(10 mglkg BW) in saline iv. Blood samples were collected via a jugular vein cannula
every 15 min for 2 hr before and 3 hr aft er treatment. and serum was handled as described
in Exp I and assayed for GH. Antibody tilers against GRF were determined as described
below.
Experiment III. Two re plicates were conducted with 12 and 6 pituitary glands per
replicate, respecti vely. Pituitary glands were aseptically re moved from cross-bred (York
shire x Landrace x Hamp~hire) g ilts weighing approximately 105 kg and 180 d of age at
slaughter. Ovaries were examined at slaughter, and giltS were considered prepuberal.
because their ovaries were devoid o r corpora a lbicantia and corpora lutea. All subsequent
procedurcs were pcriormed under sterile conditions. The anterior lobe was di ssccted from
each pituitary gland, and cells were enzymaticall y dispersed and cultured as previou>;ly
described ( 12, 13). To summari ze the culture methods, after cells were dispersed and
centrifuged. the cell pellet was res uspended in growth medium (Oul becco'>; modified
Eagle ' s medium LOM E] , Ham ' s nutrient mixt ure F-12 [F. 12])2 90% (vol/vol ; 4,500 mg/I
glucose ], and 10% Ivol/voll Filion-Jackson medium IBGjb]J containing 2 mg/ml of bo

vine serum albumin, 10 mM N-hydroxyethylpipemzine-N"-2-ethane~ulfonic acid [pH 7.21,
100 Ulml of penicillin, 250 ng/ml of amphotericin B,2 and 100 ~g/ml of ~treptomyc in to
which was added 2% [vol/vail fetal bovine serum)? which wa~ supplemented with 100
ng/ml of cortisol, 1.0 ng/ml of human insulin, 10 ~ g/ml of human transferrin,2 10 pg/ml
of glucagon, 100 pg/ml of human insulin, 10 ~glml of human transferrin,2 10 pglml of
glucagon, 100 pglml of epidermal growth factor, 200 pg/ml of bovine parathyroid hor
mone, 400 pglml of triiodothyronine,2 and 200 pg/ml of fibrobla~t growth factor. 4 Cell
viability and number were assessed by counting the number of cells excluding trypan blue
on a hemocytometer. Culture medium was changed on Day 3 (day of seeding = Day 0 of
culture) and replaced with serum-free growth medium as described before, except with
DME containing 1,000 mg of glucose/l.2 On Day 4 of culture, medium was discarded,
plates were rinsed twice with serum-free medium. and pituitary cells (lOs cells/well) were
cultured in I ml of fresh medium without serum. Cells were challenged with 1O-t> M
synthetic GRF ([Ala 1s]-hGRF(I-29)-NH2i, ASP or GLU (10- 8 , 10-6 or 10-4 M), or
2-amino-5-phosphonopentanoic acid (AP5; 10-4 M) alone or in combination with ASP or
GLU. The dose of GRF and AP5 used was based on previous observations (10). Cells
were exposed to treatment for 4 hr, at which time medium wa~ harve~ted and quantified
for GH. Therc were three to ~even wells per treatment per replicate.
Hormone Assays. Antibody titers against GRF were determined by incubating various
dilutions of serum with [ 12S I]GRF(l-44)-NH2. The antibody titer was expressed as the
initial dilution of serum from GRFi gilts required to bind 30% [12SIJGRF or percent
binding at a dilution of I: 100 in HSAi gilts. On Day I. 0.25 ml of diluted serum, 0.15 ml
of assay buffer (0.1 M acetate buffer; pH 5.6), and 0.1 ml of [mI]GRF (8,000 to 10,000
cpm in assay buffer) were aliquoted into glass 12 x 75 tubes, vortexed, and incubated for
24 hr at 4 C. Nonspecific binding was determined by incubating 0.4 ml of assay buffer
with 0.1 ml of ,1 2SI]GRF. Nonspecific binding was le s~ than 5%. On Day 2, 0.2 ml of
rabbit anti-pig gamma globulin (I: 10 in assay buffer) and 0.5 ml of6% polyethyleneglycol
in assay buffer were add to all tubes, mixed, and centrifuged at 2,000 x g for 15 min to
separate bound and free [ 125 1]GRF. The supernatant was decanted, and the radioactivity in
the remaining pellet was counted.
Radioiodination ofGRF. An aliquot of 5 ~g of GRF2 in 5 ~I of 0.01 M acetic acid was
iodinated by the chloramine-T method (14). Ten microliters of 0.5 M phosphate buffer
(pH 7.5) was added to the reaction vial contai ning the GRF, and 10 ~I of 0.05 M phosphate
buffer (pH 7.5) was added to the vial containing I mCi of [ 125I1Na, resulting in a total
volume of 20 11l. One half of the r12S I]Na in 10 111 was added to the reaction vial, and I
~g of chloramine-T (I ~ gl2 ~I of 0.05 M phosphate buffer; pH 7.5) was mixed with GRF
and [1 25l[Na for 20 s. The reaction was stopped with 2.5 ~g of sodium metabi sulfate (2.5
J-Ig/5 ~l of 0.05 M phosphate buffer; pH 7.5) added to the reaction mixture for 30 s. The
reaction mixture was diluted with 100 J-II of 0.1 % gelatin in 0.1 M acetic acid and was
layered on a 10 x I cm Biogel P_4 6 column to separate free IlS I from [ 1<!sl]G RF.
Serum concentrations of GH were quantified by RIA (15). The assay sensitivity was 0.4
nglml. Intraassay and interassay coeffi cients of variation were 3.2% and 13.6%, respec
tively.
Statistical Analysis. To determine the effect of ASP and GLU on GH secretion in Exp
I, data were subjected to the general linear model split plot-in-time analysis of variance
(ANOVA) procedure of the Statistical Analysis System (SAS: 16). The statistical model
included amino acid, dose, pig, time, and replicate. The effects of amino acid, dose, amino
acid x dose, and replicate were tested with replicate x amino acid x dose as the error term.
Replicate x amino acid x dose was tested with pig within amino acid x dose x replicate
0

as the error term. Time, lime x amino acid, time x dose, and time x amino acid x dose
were tested with amino acid x dose x lime x replicate as the error term. Differences
between treatment means within a timc were determined by least-squares contrasts (16).
In Exp II . data were subjected to the general lincar model split plol-in-lime ANOVA
( 16), Data were analyzed with pig. treatment. and lime as discrete (class) vari ables.
Treatment was tested with animal within treat ment as the error term. Time and treatment
x lime were tested with the residual as the error tenn. If a significant treatment x time
interaclion was detected then differences between treatment means wi thin a specific time
were determined by least-squares contrasts ( 16).
In Exp III , data were convened to a percentage of basal secretion before averagi ng to
minimi ze differences between replicates. To obtain an estimate of variation between
conlrol wells, medium GH concentrations for control well s were convened to a percentage
of mean basal GH concentration. This was then used to calcu late an SE for basal secretion.
Basal secretion (control) was the amount of hormone secreted into the culture medium per
103 ce lls seeded/well in the absence of a secretagogue. Convened data were tested for
homogeneity of variance by the use of Han ley's F max test (17). Data were pooled across
rep licate~ and then subjected to a one-way ANOVA ( 16). Differences between means
were determined by least-sq uares contrast ( 16).
RESULTS
There were no ami no acid x replicate x dose interactions detected in Exp I. Therefore,
data were pooled across replicates. Amino acid x dose. ami no acid x time, and dose x time
(P < 0.0 1) interactions were detected. Scrum GH conccn trati on ~ for each amino acid and
dose are depicted in Figure I. Four of the eight control animals exhibited an endogenous
GH pulse at approximately 45 min after sali ne treatment. This accounted for the increase
in GH secretion observed at th is time for control pigs in Figure I . Pretreatme nt serum GH
concentrations were similar among groups. All of the ASP doses and the 100- and 150-mg
doses of GLV increased (P < 0.05) GH secretion by 15 min after treatment when com
pared wi th the Time 0 GH concentration (Figure 1). The peak GH response was higher (P
< 0.0 1) for the 100- and 150- mg doses of ASP when compared with the correspondi ng
doses of GLV (Figure 2).
In Exp II. the antibcxly titer to GRF. expressed as percent binding at a dilution of
I:IO,(}()(), was 30.7 ± 1.4% for GRFi pigs and was less than 5% for HSAi pigs when
ex pressed as percent binding at a 1: 100 dilution. Serum GH concentrations increased (P
< 0.05 ) only in HSAi pigs and averaged 1.2 ±.2 nglm l before and 8.2 ± 0.7. 6.3 ± 0.5.
and 9.2 ± 0.5 nglml by 15 min after 150 mglkg ASP. GLU. or 10 mglkg NMA, respec
tively (Figure 3). In the NMA -treated pigs, a second increase (P < 0.05) in serum GH
concentration was observed at 75 min after treatment (Figure 3). This most likely was d ue
to a spontaneous GH pulse occause GH concentrations returned to control levels by 45
min after NMA.
In Exp 11.1. basa l GH secretion by pituitary cells (lOs cells/well) was 40 ± 6 ng/ml (n =
14) and GH concentratio ns increased (P < 0.05) threefold after 10-6 M GRF compared
with control (Figure 4). Relative to control. GH concentrations increased (P < 0.05) 1.6.
1.9. and 1.9-fold and 1.7. 1. 8, and 2.0-fold after 10- 8. 10-6. and 10-4 M ASP or GLU.
respectively (Figure 4). The EAA receptor antagonist AP5 failed to prevent the GH
response to ASP or GLU. except for 10- 8 M ASP (Figure 5).
mSCUSSION
The results of this study indicate that both ASP and GLU enhanced GH secretio n in the
prepuberal gi lt. although ASP is a more potent secretagogue of GH secretion than GLU.
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Fi gure l. Seru m GH cOllCcntracions (mean ± SE) for pi gs treated with 0 (conlrol; n :; 8) 50 (n = 6), 100 (n '"
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In Exp II, ASP, GLU , and NMA all stimulated GH secretion in mature ovariectomized
gilts. We previously demonstrated thai Ihe systemic admini Slr31ion of NMA stimulated
GH secretion in the mature gilt (9). Moreover, NMA stimulated GH secretion and accel~
erated growth in prepuberal monkeys (5) and dramatically increased concentrations of GH
in gonadectomized male (7) and female (6) sheep. Funher studies are now warranted to

"

Figure 2. Mean (±SE) seru m GH concentrations by 15 min aftcr treatmcnt with salitH: (0; n '" 8). 50 (n : 6). 100
(n :; 6). or 150 mg (n = 6)Jkg BW of ASP or GLU. Column$ with different leuers differ (P < 0 .01 ).
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Figure 3. Serum GH co ncentrations (mean ± SE) before and after 150 mg/kg BW of ASP. GL U or 10 mg/kg
BW NMA (Ircatmenl '" Time 0) for pigs immun ized against GRFi (n '" 4) or HSAi (n '" 5). Sample times al which
significant effects of treatme nt were detected arc indica ted .• 1' < 0.05.

test whether the GH response is specific for each EAA and whether EAA plays a phys
iologic role in the control of GH secretion.
Acs CI al. (18) reported that NMA failed to increase GH secretion when rals' were
prelrealed with monosodium glutamate, which resulted in the destruction of hypothalamic
neurons. Moreover, [rcalmen! wilh the NMA receptor antagonist MK-801 reduced hypo
thalamic GRF mRNA concentrations ( 19). The failure of exogeno u!>ly administered EAA
or NMA to increase GH secretion in pigs immunized against GRF suppons the idea of a
eNS site of action. Neural loci at which systemically administered EAA may act to affect
G H release include the areas of the brain that lack a d istinct blood-brain barrier. Price et
al. (2) demonstrated the preferential uptake of exogcnous ASP or GLU by the circum
ventricular organs of the rat brain , incl uding the arcuate nucleus. The systemic injection
of GLU increased GlU levels fourfold in the median eminence, but not in other areas of
the hypothalamus in mice (3). lbcrefore, EAA might affect GH secretio n by influencing
GRF release from nerve tenninals in the median e minence.
Alternat ively. the immunoneutrali zation of GRF in this study may have altered the
pituitary responsiveness to GRF secretion and the subsequent GH response to exoge
nously administered ASP, GlU, or NMA. [n contrast, Klindt et al. (20) reported that
viable somatotTOphs were present after hypophyseal !>talk tran!>ection in the pig in the
absence of hypothalamic stimulatory input. Moreover, hypophyseal stalk-transacted gilt!>
remained acutely re!>ponsivc to GRF admi nistration. exhibiting a twofold higher GH peak
release than control animal s (21) . Therefore, it is likely that pitui taries of GRFi pigs
remained responsive to GRF.
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The influence of EAA on GH secretion was observed at all concentrations of the amino
acids added to porcine pituitary cells in culture. A lack of a dose-dependem response 10
ASP and GLU and the failure of the EAA receptor antagonist AP5 to reverse stimulation
by ASP and GLU on GH secrelion suggest a possible nonspecific response rather than a
response involving specific receptor activation. We previously reported Ihat 10-4 M AP5
failed to block the NMA-induced release of GH from pig piluitary cell in vitro, although
Ihi s dose of AP5 antagonized the action of NMA on IUleinizing honnone secretion (10).
Therefore, it is possible that EAA receptors associated with GH secretion may not be
antagonized by AP5 or the dose of AP5 used was insufficient to block the effects of ASP
and GLU. Lindstrom and Ohlsson (22) reported thai NMA stimulaled GH secretion from
isolaled rat somatotroph ~ and that Ihis effeci was blocked by NMA receptor antagonists.
In conlrm\l, Acs et al. (18) and Caeilovo el al. (19) failed to demonstrate the stimulation
ofGH secrelion from rat pituitary cells by NMA in culture. The apparent paradox between
the in vivo and in vitro results in this study, together with previously published dala,
indicate that the EAA act at Ihe level of the pituitary and CNS to modulate GH secretion.
However, the results from Exp 11 suggest that the EAA act primarily at the level of the
h ypOl halamu ~ or higher brain centers 10 release GH, because the EAA-induced release of
GH was blocked in GRFi gilts.
GLU and ASP nOI only act as neurotransmitters in the CNS, but also can be used in a
more nonspecific way as amino acid substrate~. Plasma concentralions of GLU and ASP
nonnally range between 0.3 and 0.6 mM and 0.03 and 0.1 mM. respectively (23). This is
comparable to the concentrations of ASP and GLU used in this study. Blood concentra
tions of GLU and ASP can be altered by pathologic condition (24,25), fasting, and diet

300

200

o

0

z

a

~ .00
~

U

w

~

"
0

~

0
300

GLUTAMATE (1.4 )

"a

~

200

.00

AP5(1.4)
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(23). It is conceivable Ihal an aheration in the serum concentrations of Ihese amino acids
could influence GH secretion. In support of this idea. Ihe median eminence, which con
tains fiber projections from GRF perikarya located in the median basal hypothalamus (26),
and pituitary gland lie outside of the blood-hrain barrier (27). Therefore, serum concen
trations of GLU and/or ASP may influence hypothalamic GRF secretion, but also may
have a direct effect on the pituilary gland.
In summary, ASP is a more potent secretagogue of GH secretion than GLU in vivo
although each is equipotent in vitro. Because no stimulation of GH seerelion by EAA was
observed in ORFi pigs and no dose-response effect of EAA was found in vitro, it is
concluded that the modulalion of OH secretion by EAA is mediated primarily al the level
of the hypothalamus or higher brain centers.
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